Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report

Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report

Abstract A 72‐year‐old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that binds to the epidermal growth factor receptor (EGFR), as a sixth‐line treatment. Tumor shrinkage was observed, but asymp...

Full description

Bibliographic Details
Main Authors: Akira Nakao, Hiroyuki Inoue, Yusuke Osaki, Ryosuke Hirano, Taishi Harada, Takashi Aoyama, Fumiyasu Igata, Masaki Fujita
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Thoracic Cancer
Subjects:
cisplatin
gemcitabine
hypomagnesemia
necitumumab
squamous cell lung cancer
Online Access:https://doi.org/10.1111/1759-7714.13999

Internet

https://doi.org/10.1111/1759-7714.13999

Similar Items